EGFR and neoplasm: Even though certain EGFR IgG1 monoclonal antibody combinations such as Sym004 and MM-151 showed superior anticancer efficacy in several human tumor xenograft models, their effects on ADCC were only investigated in EGFR amplified cell lines [11, 29].